HOXA11 and central nervous system cancer: Moreover, Xu et al demonstrated that HOXA11‐AS exerted its oncogenic functions in glioma cells by epigenetically suppressing miR‐130a‐5p.20 Consistently, we observed notably increased miR‐130a‐5p expression after silencing of FEZF1‐AS1 in COC1, SKOV‐3 and PEO1 cells.